Innoviva (INVA) Minority Interest (2017 - 2021)
Innoviva posted quarterly Minority Interest of $111.2 million for Q4 2021, up 63.7% year-on-year from $67.9 million in Q4 2020, and up 24.94% on a QoQ basis from $89.0 million in Q3 2021.
Innoviva (INVA) has 5 years of Minority Interest data on file, last reported at $111.2 million in Q4 2021.
- For the quarter ending Q4 2021, Minority Interest rose 63.7% year-over-year to $111.2 million; the trailing twelve-month figure through Dec 2021 stood at $111.2 million (up 63.7% YoY), and the FY2021 full-year result was $111.2 million, up 63.7% from the prior year.
- Minority Interest for Q4 2021 stood at $111.2 million, up from $89.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $111.2 million in Q4 2021 and bottomed at $152000.0 in Q4 2017.
- The 5-year median for Minority Interest is $26.3 million (2020), against an average of $35.0 million.
- The widest annual swing landed in 2018, when Minority Interest jumped 3498.03%; it then surged 63.7% in 2021.
- A 5-year view of Minority Interest shows it stood at $152000.0 in 2017, then surged by 3498.03% to $5.5 million in 2018, then surged by 423.33% to $28.6 million in 2019, then surged by 137.33% to $67.9 million in 2020, then soared by 63.7% to $111.2 million in 2021.
- The last three Minority Interest figures came in at $111.2 million (Q4 2021), $89.0 million (Q3 2021), and $64.0 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 111.19 Mn |
| Sep 30, 2021 | 88.99 Mn |
| Jun 30, 2021 | 63.97 Mn |
| Mar 31, 2021 | 62.22 Mn |
| Dec 31, 2020 | 67.93 Mn |
| Sep 30, 2020 | 49.32 Mn |
| Jun 30, 2020 | 35.91 Mn |
| Mar 31, 2020 | 26.33 Mn |
| Dec 31, 2019 | 28.62 Mn |
| Sep 30, 2019 | 16.71 Mn |
| Jun 30, 2019 | 20.02 Mn |
| Mar 31, 2019 | 11.70 Mn |
| Dec 31, 2018 | 5.47 Mn |
| Sep 30, 2018 | 3.08 Mn |
| Jun 30, 2018 | 1.99 Mn |
| Mar 31, 2018 | 811,000.00 |
| Dec 31, 2017 | 152,000.00 |